neuroClues closes €10M Series A to bring its eye-tracking Parkinson’s diagnostic to European and US neurologists

The Next Web
Read full post
NeuroClues secured €10 million in Series A funding to advance its eye-tracking technology for Parkinson's diagnosis, aiming to expand access among neurologists in Europe and the US. The funding will support clinical trials and regulatory approvals to bring this diagnostic tool to market.

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources
Healthcare6 min read

NYU-DRP AI Model Predicts Five-Year Breast Cancer Risk From 3D Mammograms

Unite.AI
Healthcare3 min read

Google’s map of every possible DNA typo could speed up rare disease research

Covered by 3 sources